GL1X · GenesisL1 explorer

Research workbench

HIV reverse transcriptase complexed with (E)-3-(pyrimidin-2-yl)-N-(5- (5,6,7,8-tetrahydronaphthalen-2-yl)-1H-pyrazol-3-YL)ACRYLAMIDE

Analyse HIV reverse transcriptase complexed with (E)-3-(pyrimidin-2-yl)-N-(5… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5VZ6
Type
protein
Length
954 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
HIV reverse transcriptase
EC
2.7.7.49, 2.7.7.7, 3.1.26.13, 3.1.13.2
UniProt
P04585
Ligands
9TV
Pockets
17 · best druggability 0.73

Structure

x-ray diffraction · 2 distinct chains · 35% helix, 22% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHIV reverse transcriptase (EC 2.7.7.49, 2.7.7.7, 3.1.26.13, 3.1.13.2)protein55432% helix, 24% strandP04585
BHIV reverse transcriptase (EC 2.7.7.49, 2.7.7.7, 3.1.26.13, 3.1.13.2)protein40039% helix, 19% strandP04585

Ligands and binding sites

  • 9TV · 3-(pyrimidin-2-yl)-N-[3-(5,6,7,8-tetrahydronaphthalen-2-yl)-1H-pyrazol-5-yl]propanamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

17 pockets found on a 1 Å grid, 6 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16060.730.8061empty
25660.710.7947empty
31010.690.91189TV
42410.660.8337empty
51510.540.8034empty

Interfaces

1 interface between chains.

  • A–B · 2884 Ų buried · 28 hydrogen bonds · protein-protein

Compared structures

  • 5VZ6 · HIV Reverse Transcriptase complexed with (E)-3-(pyrimidin-2-yl)-N-(5-(5,6,7,8-tetrahydrona… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.